Dont Fear POTS Tips for Diagnosis and Treatment

Video Description

Postural orthostatic tachycardia syndrome can challenge doctors. Cardiologists Pam Taub and Michelle O'Donoghue discuss how to diagnose and treat, and when to refer to a specialty clinic. https://www.medscape.com/viewarticle/995674?src=soc_yt -TRANSCRIPT- Michelle L. O'Donoghue, MD, MPH: Hi. This is Dr Michelle O'Donoghue, reporting for Medscape. I'm here in Amsterdam at the European Society of Cardiology (ESC) Congress 2023. Joining me for a great discussion is my friend Dr Pam Taub, who is a cardiologist and a professor of medicine at UC San Diego. She has a particular interest in postural orthostatic tachycardia syndrome (POTS), so that's what we'll be talking about today. Thanks for joining me, Pam. When we think about POTS, for those who are not familiar with the term, what does it actually mean and how do you diagnose it? No Tilt Table Required Pam R. Taub, MD: As you said, it's postural orthostatic tachycardia syndrome. What that means is when somebody stands up, they have an elevation in their heart rate that is usually 30 points from when they're lying down. That's typically associated with symptoms such as lightheadedness, dizziness, and cognitive difficulties such as brain fog. The diagnosis can be made by tilt-table testing, but it can also be made in the office with simple orthostats. In my clinic, I have people lie down for 3-5 minutes. At the end of that period, you get a heart rate and blood pressure. Then you have them stand up for 3-5 minutes and then get heart rate and blood pressure, and you look at the differences. If the heart rate goes up by 30 points — so maybe they're 80 beats/min when they're lying down and when they stand up, it goes to 110 beats/min — that's POTS, so very objective criteria. Typically, these people don't have what we call orthostatic hypotension, where there is a significant decrease in the blood pressure. It's more a heart rate issue. O'Donoghue: How symptomatically do they usually present? Taub: It's a spectrum. Some people have mild symptoms. After they're in the upright position for maybe 10 minutes, they get symptoms. There are some people who, when they go from a lying to standing position, they're extremely symptomatic and can't really do any activities. There are some people that are even wheelchair-bound because the symptoms are so debilitating. There's a wide spectrum. O'Donoghue: There has been more discussion, I feel like, about the rising prevalence of POTS as a diagnosis, and in particular since the COVID pandemic. What's our understanding of the relationship between COVID and POTS and what the mechanism might be? Taub: We've known that POTS can be triggered by a viral infection. Before COVID, we knew that in certain individuals that we think have an underlying genetic predisposition, usually some autoimmune substrate, when they get certain types of infections, whether it's influenza or mononucleosis, they get POTS. Typically, when they get an infection, they start getting deconditioned. They don't feel well, so they're on bedrest. When they get long periods of bed rest, when they start to become active, they start to have overactivation of their sympathetic nervous system and they have a large amount of cardiovascular deconditioning. It's a cycle that is often triggered after an infection. A huge increase of POTS has been seen after COVID-19 because we had so many people exposed to this virus. With COVID-19, there is a period where people don't feel great and they are getting bedrest, so they're getting deconditioned. We've seen so many patients referred for post-COVID POTS and also long COVID or the post-acute sequelae of COVID-19, where POTS is a part of that presentation. Female Sex and Autoimmune Conditions O'Donoghue: We know that POTS seems to disproportionately affect women. Is that understood? Is it thought that that's related to the perhaps the autoimmune component of that illness? Taub: Yes. The theory is because women tend to have more autoimmune conditions, that's why they're more predisposed. There's a large amount of genetic susceptibility. For instance, we know that there's an association between POTS and conditions like Ehlers-Danlos syndrome and between POTS and mast cell activation. Some of those conditions are more prevalent in women as well. O'Donoghue: I feel like many physicians don't know how to manage POTS, and they're actually a little fearful perhaps to take it on. Fortunately, there have been a growing number of POTS clinics with specialists that focus on that area. For the average practitioner who maybe can't refer to a POTS clinic, how should they approach that? https://www.medscape.com/viewarticle/995674?src=soc_yt